Digestion and metabolism
Unlike alpha- and beta-cyclodextrin, which resist digestion in the small intestine and reach the colon largely intact, gamma-cyclodextrin is rapidly broken down by amylase enzymes in the small intestine. It is effectively treated by the body as a digestible starch. JECFA noted that rat studies at dietary concentrations up to 20% showed no toxic effects, and a human study found it produced no adverse effects at 8g per serving with no adverse gastrointestinal symptoms.
Gamma-cyclodextrin is rapidly digested by salivary and pancreatic alpha-amylase, unlike alpha- and beta-cyclodextrin, which are largely stable toward amylase in the upper gut.
2000Regulatory reviewJECFA, WHO Food Additives Series 44, Monograph 969, Cyclodextrin gamma
In a 12-month rat feeding study at dietary concentrations up to 20% gamma-cyclodextrin, no toxic effects were observed. Minor changes in caecal weight were attributed to osmotic effects of any undigested fraction rather than toxicity.
2000AnimalJECFA, WHO Food Additives Series 44, Monograph 969, Cyclodextrin gamma
Human subjects consuming 8g of gamma-cyclodextrin per serving reported no adverse gastrointestinal symptoms, and JECFA allocated an ADI 'not specified', indicating no health concern at levels needed for intended food use.
2000RegulatoryJECFA, WHO Food Additives Series 44, Monograph 969, Cyclodextrin gamma
Regulatory status: not authorised in UK or EU
The UK FSA approved-additives list (updated July 2025) does not include E458. Annex II of assimilated EU Regulation 1333/2008 also does not list E458. The authorised cyclodextrin in UK and EU food law is E459 (beta-cyclodextrin). E458 therefore lacks the legal basis to be used as a food additive in Great Britain or the EU, regardless of its JECFA evaluation.
E459 (beta-cyclodextrin) is listed as a permitted food additive in Annex II of EU Regulation 1333/2008 (assimilated into UK law). E458 (gamma-cyclodextrin) does not appear in that list.
2025RegulatoryUK FSA Approved Additives and E Numbers list; assimilated EU Regulation 1333/2008 Annex II